COVID-19 vaccination coverage in the EU/EEA during the 2024–25 season campaigns

During the reporting period, 21 out of 30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one group (people aged 60 years and above, people aged 80 years and above, healthcare workers, people with chronic conditions, pregnant women). During this period, approximately 13.6 million people aged 60 years and above received one COVID-19 vaccine dose. Of these, approximately four million people were aged 80 years and above. The median COVID-19 vaccination coverage among people aged 60 years and above was 8.7% (range: <0.1–52.8%), with high variation among countries. For people aged 80 years and above, the median coverage was 8.5% (range: 0.9–83.5%), with high variation among countries. Among the 21 reporting countries, one country reported a vaccination coverage ≥50% for the age group 60 years and above, while seven countries reported a vaccination coverage ≥50% for the age group 80 years and above. The number of countries increased to eight for those reporting a vaccination coverage of > 30% for the age group 60 years and above, and to nine for the age group 80 years and above. Most of the approximately 15.5 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Pfizer BioNTech – Comirnaty JN.1 vaccine (around 11.3 million doses; 73.3% of the total doses administered).